Summary
The product Primo E-100 (Methenolone Enanthate 100 mg), manufactured by Intex Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number O-2205, was submitted by Intex Pharma and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of Methenolone Enanthate at 104.52 mg/ml, which is 4.52% above the labeled claim of 100 mg/ml.
The testing process began on 8 October 2024, with the sample received on 22 October 2024, and analysis completed on 25 October 2024. While the results confirm the presence of the expected compound, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Intex Pharma
- Product Name: Primo E-100 (Methenolone Enanthate 100 mg)
- Active Ingredient: Methenolone Enanthate
- Batch Number: O-2205
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51221
- Testing Ordered: 8 October 2024
- Sample Received: 22 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Intex Pharma (Manufacturer)
- Analysis Paid For By: Intex Pharma (Manufacturer)
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 104.52 mg/ml
- Accuracy: 104.52% (4.52% above the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51221_NUYPJK7DCLWX
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Methenolone Enanthate is present at 104.52 mg/ml, which is slightly above the expected concentration. While this deviation is minor and does not indicate a significant concern, ensuring consistent dosing is crucial for maintaining product quality. Since Intex Pharma submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that Primo E-100 contains Methenolone Enanthate at 104.52 mg/ml, which is 4.52% above the labeled claim. While this batch exhibits high purity and a slightly higher concentration, continued testing is essential to ensure consistent dosing across different production runs. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
